Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmac...
FDA Recall #D-0357-2026 — Class II — January 29, 2026
Product Description
Metoprolol Succinate Extended-Release Tablets, 200 mg, 100 tablets bottles, Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054, NDC: 45963-678-11
Reason for Recall
Failed Dissolution Specifications
Recalling Firm
Teva Pharmaceuticals USA, Inc — Parsippany, NJ
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
19,056 bottles
Distribution
Nationwide
Code Information
Lot#: a) 0686H251, 0687H251, 10688H251, Exp.: 02/2027. .
Status
Ongoing
Voluntary / Mandated
Voluntary: Firm initiated